nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard
|
Stabile, Armando |
|
|
5 |
1 |
p. 1-17 |
artikel |
2 |
Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy
|
Fasulo, Vittorio |
|
|
5 |
1 |
p. 61-69 |
artikel |
3 |
Contents
|
|
|
|
5 |
1 |
p. iii-v |
artikel |
4 |
Deep Learning-based Recalibration of the CUETO and EORTC Prediction Tools for Recurrence and Progression of Non–muscle-invasive Bladder Cancer
|
Jobczyk, Mateusz |
|
|
5 |
1 |
p. 109-112 |
artikel |
5 |
Editorial Board
|
|
|
|
5 |
1 |
p. i-ii |
artikel |
6 |
Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non–muscle-invasive Bladder Cancer
|
Galesloot, Tessel E. |
|
|
5 |
1 |
p. 70-83 |
artikel |
7 |
Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging
|
Ma, Ting Martin |
|
|
5 |
1 |
p. 100-103 |
artikel |
8 |
Locally Advanced Kidney Cancer: A New Space for Immunotherapy?
|
Singla, Nirmish |
|
|
5 |
1 |
p. 118-119 |
artikel |
9 |
Metastases-directed Therapies in the Prostate-specific Membrane Antigen Era: Not All That Glitters Is Curable
|
Gandaglia, Giorgio |
|
|
5 |
1 |
p. 52-53 |
artikel |
10 |
Molecular Characterization of Clear Cell Renal Cell Carcinoma Reveals Prognostic Significance of Epithelial-mesenchymal Transition Gene Expression Signature
|
Nallandhighal, Srinivas |
|
|
5 |
1 |
p. 92-99 |
artikel |
11 |
Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell Carcinoma
|
Gorin, Michael A. |
|
|
5 |
1 |
p. 113-117 |
artikel |
12 |
Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy
|
Laukhtina, Ekaterina |
|
|
5 |
1 |
p. 120-124 |
artikel |
13 |
Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation Panel
|
Mahal, Brandon A. |
|
|
5 |
1 |
p. 18-29 |
artikel |
14 |
Prostate Cancer Screening with Magnetic Resonance Imaging: Results from the Second Round of the Göteborg Prostate Cancer Screening 2 Trial
|
Wallström, Jonas |
|
|
5 |
1 |
p. 54-60 |
artikel |
15 |
Three-dimensional Virtual Models’ Assistance During Minimally Invasive Partial Nephrectomy Minimizes the Impairment of Kidney Function
|
Amparore, Daniele |
|
|
5 |
1 |
p. 104-108 |
artikel |
16 |
Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography–staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical Trial
|
Hölscher, Tobias |
|
|
5 |
1 |
p. 44-51 |
artikel |
17 |
Treatment Options for De Novo Metastatic Clear-cell Renal Cell Carcinoma: Current Recommendations and Future Insights
|
Benamran, Daniel |
|
|
5 |
1 |
p. 125-133 |
artikel |
18 |
Updated European Association of Urology (EAU) Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin
|
Lobo, Niyati |
|
|
5 |
1 |
p. 84-91 |
artikel |
19 |
Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors
|
Lonati, Chiara |
|
|
5 |
1 |
p. 30-41 |
artikel |
20 |
Upper Urinary Tract Urothelial Carcinoma in Lynch Syndrome Patients: The Urologist Still Has a Role in Genetic Screening
|
Grobet-Jeandin, Elisabeth |
|
|
5 |
1 |
p. 42-43 |
artikel |